Previous 10 | Next 10 |
NantKwest (NASDAQ: NK ) to offer shares in an underwritten public offering, and underwriters will have an option to purchase up to an additional 15% of the shares offered. More news on: NantKwest, Inc., Healthcare stocks news, , Read more ...
NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. In addition, NantKwest expects to grant the...
Shares of NantKwest (NASDAQ: NK) are up 40% at 12:40 p.m. EDT after the company's CEO Patrick Soon-Shiong made an appearance on Fox Business' Maria Bartiromo's Wall Street to talk about NantKwest's COVID-19 vaccine. While other companies such as Moderna (NASDAQ: MRNA) and Inovio (N...
Gainers: Sintx Technologies (NASDAQ: SINT ) +169% . More news on: Sintx Technologies, Inc., Evoke Pharma, Inc., Ideanomics, Inc., Stocks on the move, , Read more ...
Evoke Pharma (NASDAQ: EVOK ) +85% on FDA approval . More news on: Evoke Pharma, Inc., Theratechnologies Inc., Broadway Financial Corporation, Stocks on the move, , Read more ...
The stock market has come storming back from its March lows, and now the major benchmarks are right around positive territory for the year. Investors who were able to buy -- or simply hold -- have been rewarded as many beaten-down stocks recaptured, and then some, the short-term losses they may ...
Gainers: Wah Fu Education (NASDAQ: WAFU ) +257% . More news on: Wah Fu Education Group Limited, Wins Finance Holdings Inc., Celldex Therapeutics, Inc., Stocks on the move, , Read more ...
Wah Fu Education (NASDAQ: WAFU ) +405% . More news on: Wah Fu Education Group Limited, DarioHealth Corp., Ambow Education Holding Ltd., Stocks on the move, , Read more ...
NantKwest’s antibody-targeted NK cell line, haNK, which is engineered for increased antibody-dependent cell-mediated cytotoxicity and activation, showed increased resistance to hypoxic conditions as seen in suppressive tumor microenvironments NantKwest’s PD-L1 t-haN...
Greenpro Capital (NASDAQ: GRNQ ) -24% . More news on: Greenpro Capital Corp., Euroseas Ltd., Zafgen, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
NantKwest Company Name:
NK Stock Symbol:
NASDAQ Market:
Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility PR Newswire A TotalEnergies solar and battery storage solution to bring 130-year-old Lompoc industrial site into new era of sustainability and smart energy manag...
Creates Leading Immunotherapy and Cell Therapy Company ImmunityBio , Inc. and NantKwest , Inc. ( NASDAQ: NK ), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditi...
NantKwest, Inc . ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger of NantKwest and ImmunityBio, Inc. presented at the special ...